A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
作者信息
Rørth M, Løber J, Dombernowsky P, Krusenstjerna-Hofstrom D, Mattsson W, Mouridsen H T
出版信息
Eur J Cancer (1965). 1980;Suppl 1:137-40.
PMID:7032923
Abstract
摘要
相似文献
1
A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
Eur J Cancer (1965). 1980;Suppl 1:137-40.
2
A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
Cancer. 1983 Nov 1;52(9):1570-6. doi: 10.1002/1097-0142(19831101)52:9<1570::aid-cncr2820520905>3.0.co;2-w.
3
Prednimustine in advanced breast cancer: a review.
Semin Oncol. 1986 Mar;13(1 Suppl 1):27-31.
4
Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
Cancer Treat Rep. 1987 Nov;71(11):1107-8.
5
Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
Cancer. 1980 Jul 15;46(2):253-5. doi: 10.1002/1097-0142(19800715)46:2<253::aid-cncr2820460205>3.0.co;2-1.
6
Premarin priming before prednimustine, high-dose folinic acid and 5-fluorouracil as salvage chemotherapy for advanced breast cancer.
Chemioterapia. 1988 Apr;7(2):130-2.
7
Prednimustine in advanced malignant melanoma: a phase II study.
Cancer Treat Rep. 1987 Dec;71(12):1315-6.
8
Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
Cancer Treat Rep. 1982 Dec;66(12):2081-3.
9
Phase II study of Leo 1031 (prednimustine) in advanced ovarian carcinoma.
Cancer Treat Rep. 1979 Mar;63(3):421-4.
10
Preliminary clinical study of prednimustine in lung cancer.
J Med. 1977;8(2):115-21.
Zotero 插件